Median PFS ( progression-free survival ) was @ years for capecitabine and @ years for S-@ , with a hazard ratio ( S-@ / capecitabine ) of @ ( @ % confidence interval -LSB- CI -RSB- @-@ @ ) ( P = @ by log-rank ) .